ºÚÁÏÍø

ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
ºÚÁÏÍø

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ ºÚÁÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

ºÚÁÏÍø Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 1089

Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Euro Pub
  • ICMJE
Share This Page

Pre-exposure prophylaxis (PrEP) accessibility research and evaluation 2 (PrEPARE 2): HIV risk perception among men who have sex with men (MSM)

4th International Pharma & Clinical Pharmacy Congress

Evan Mulvihill, Sonia Jain, Shelly Sun, Marvin Hanashiro, Sheldon Morris and Jill Blumenthal

University of California, USA

Posters & Accepted Abstracts: Clin Pharmacol Biopharm

DOI:

Abstract
Background: Despite greater access to PrEP, a barrier to HIV prevention is inaccurate risk perception by MSM. PrEPARE2 is a randomized controlled trial to determine if providing at-risk HIV-uninfected MSM with a calculated risk score affects PrEP uptake. Objective: Our objective is to compare self-perceived risk (SPR) to an objective HIV risk score (UCSD score). Methods: HIV-uninfected, at-risk MSM were recruited from San Diego testing sites. At-risk for HIV can be defined as having one or more episodes of insertive or receptive condomless anal intercourse (CAI) with a HIV-infected partner or partner of unknown status within 6 months. Enrolled subjects received an iPad survey to assess baseline characteristics including demographics and risk behaviors. SPR score was the subject�s perceived likelihood of becoming HIV-infected. The survey also generates the UCSD score, which calculates an individual�s risk of becoming infected over one year and places individuals into risk categories, calculated from event frequencies of UAI, history of sexually transmitted infections and shared needle events. SPR and UCSD score categories include low, medium, high and very high. Cohen�s kappa coefficient evaluated the agreement between the two measures. Results: Of 78 participants enrolled, median age was 32, 31% identified as Latino, 67% as white, 13% as black. Most subjects had heard of PrEP (78%), and 53% thought they were good candidates for it. Overall, the group had a median of 5 sexual partners in the last 6 months (IQR: 3-10) and 72% had at least one receptive CAI within the past 6 months. The SPR had poor agreement with the objective score (kappa=0.009). Most subjects (55%) underestimated their HIV risk, 36% had concordant predictions, and 9% overestimated their risk. 15 of 16 subjects with a high UCSD score underestimated their risk. Underestimation of risk was not associated with any demographic or risk factors, including number of sex partners and drug use. Conclusions: In this sample of HIV-negative MSM, there was high discordance between self-perceived and actual HIV risk and a tendency to underestimate risk, particularly in high-risk individuals. Greater emphasis on objective HIV risk may be an important component of successful PrEP uptake.
Biography

Email: d.evan.mulvihill@gmail.com

International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top